1. Home
  2. LGND vs CAMT Comparison

LGND vs CAMT Comparison

Compare LGND & CAMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • CAMT
  • Stock Information
  • Founded
  • LGND 1987
  • CAMT 1987
  • Country
  • LGND United States
  • CAMT Israel
  • Employees
  • LGND 68
  • CAMT N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • CAMT Electronic Components
  • Sector
  • LGND Health Care
  • CAMT Technology
  • Exchange
  • LGND Nasdaq
  • CAMT Nasdaq
  • Market Cap
  • LGND 3.2B
  • CAMT 3.8B
  • IPO Year
  • LGND 1992
  • CAMT 2000
  • Fundamental
  • Price
  • LGND $169.53
  • CAMT $100.71
  • Analyst Decision
  • LGND Strong Buy
  • CAMT Strong Buy
  • Analyst Count
  • LGND 8
  • CAMT 11
  • Target Price
  • LGND $144.71
  • CAMT $96.91
  • AVG Volume (30 Days)
  • LGND 139.7K
  • CAMT 394.6K
  • Earning Date
  • LGND 08-05-2025
  • CAMT 11-11-2025
  • Dividend Yield
  • LGND N/A
  • CAMT 1.55%
  • EPS Growth
  • LGND N/A
  • CAMT 38.64
  • EPS
  • LGND N/A
  • CAMT 2.73
  • Revenue
  • LGND $181,488,000.00
  • CAMT $471,588,000.00
  • Revenue This Year
  • LGND $18.41
  • CAMT $17.22
  • Revenue Next Year
  • LGND $18.87
  • CAMT $8.35
  • P/E Ratio
  • LGND N/A
  • CAMT $31.42
  • Revenue Growth
  • LGND 53.40
  • CAMT 27.88
  • 52 Week Low
  • LGND $81.74
  • CAMT $47.41
  • 52 Week High
  • LGND $129.90
  • CAMT $110.73
  • Technical
  • Relative Strength Index (RSI)
  • LGND 72.58
  • CAMT 71.43
  • Support Level
  • LGND $161.82
  • CAMT $85.38
  • Resistance Level
  • LGND $169.00
  • CAMT $88.64
  • Average True Range (ATR)
  • LGND 3.90
  • CAMT 3.37
  • MACD
  • LGND -0.81
  • CAMT 1.84
  • Stochastic Oscillator
  • LGND 98.73
  • CAMT 98.92

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About CAMT Camtek Ltd.

Camtek Ltd is engaged in the manufacturing of metrology and inspection equipment and software solutions for the semiconductor industry. Its systems inspect wafers for various semiconductor market segments, including Advanced Packaging, Heterogenous Integration (HI), Compound Semiconductors, Memory, and foundries among others. Geographically, it derives maximum revenue from China followed by Asia Pacific, Korea, United States, and Europe. The company's products and services include Surface Inspection, Bump Inspection and Metrology, and others.

Share on Social Networks: